March 4, 2021 News by Forest Ray PhD #ACTRIMS2021 – Benign Versus Aggressive MS ā the Hunt for Clues Editorās note: TheĀ Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25ā27. GoĀ hereĀ to see the latest stories from the conference. While researchers make progress in pinpointing markers of disease progression in multiple sclerosis (MS), identifying those that signal…
August 21, 2018 News by Patricia Inacio, PhD Deregulated RNA Molecules May Contribute to RRMS, Study Finds The levels of three small, regulatory RNA molecules ā long non-coding RNAs ā are deregulated in blood samples of patients with relapsing-remitting multiple sclerosis (RRMS), a study reports. The long non-coding RNAs are involved in the regulation of the natural immune response and DNA-damage response, supporting the theory that these…
October 27, 2017 News by Alice MelĆ£o, MSc #MSParis2017 ā Anti-inflammatory Therapies May Be More Beneficial for Younger SPMS Patients, Study Suggests Older patients with secondary progressive multiple sclerosis (SPMS) have reduced risk of experiencing disease relapse, according to a study presented at theĀ 7th Joint ECTRIMS-ACTRIMS Meeting, being held Oct. 25-28, in Paris, France. The study, āRelapses in patients with secondary progressive MS: a matter of disease duration…
July 22, 2016 News by InĆŖs Martins, PhD Disease Modifying Drugs Seen to Help Protect MS Patients with Benign Status from Greater Disability Women with multiple sclerosis (MS) and people diagnosed with the disease at aĀ younger age are more likely to have a benign course of MS, remaining fully functional for decadesĀ after disease onset, according to researchers at the School of Medicine and Biomedical Sciences in New York. Disease modifying drugs wereĀ also found…
June 7, 2016 News by Patricia Silva, PhD #CMSC16 – MS Duration and Disability Level Variously Impacts Arm Function Most research in multiple sclerosis (MS) has focused on the impact of the disease on the lower extremities. To balance this, researchers at Mount Sinai Rehabilitation Hospital in Connecticut thoroughly characterized upper arm and hand functions in MS patients, finding that disease duration and disability level differently affected various…
July 20, 2015 News by Patricia Silva, PhD Study on French MS Population Reveals Long Disease Duration is Associated with Higher Mortality A study recently published in the journal PLoS One revealed an excess mortality rate among French patients with multiple sclerosis (MS) that experience the disease for more than 20 years. The study was conducted by researchers at several institutes and hospitals in France, and is entitled ā…